| 1 |
34218992 | Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders. | 2022 Feb |
1 |
| 2 |
34647379 | Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series. | 2022 Feb |
1 |
| 3 |
33140519 | Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA. | 2021 Jun |
1 |
| 4 |
30102427 | Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. | 2019 Feb |
5 |
| 5 |
31028107 | In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome. | 2019 Jul |
1 |
| 6 |
31040679 | Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3). | 2019 |
1 |
| 7 |
31254971 | Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. | 2019 Dec |
1 |
| 8 |
29257919 | A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. | 2018 Jan 28 |
1 |
| 9 |
27898496 | Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. | 2017 Jan/Feb |
1 |
| 10 |
26948856 | Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. | 2016 Aug |
1 |
| 11 |
25312475 | Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. | 2015 Jan |
1 |
| 12 |
25935736 | Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. | 2015 Jul 1 |
1 |
| 13 |
24695018 | A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic. | 2014 May-Jun |
1 |
| 14 |
24999060 | Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. | 2014 Sep 1 |
1 |
| 15 |
23707283 | Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. | 2013 Aug |
1 |
| 16 |
21852093 | Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. | 2012 Mar |
2 |
| 17 |
22980449 | Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model. | 2012 Dec |
1 |
| 18 |
20672450 | Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir. | 2010 Aug |
2 |
| 19 |
19325013 | Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. | 2009 Jun |
1 |
| 20 |
21197300 | Transdermal buprenorphine - a critical appraisal of its role in pain management. | 2009 Sep 15 |
1 |
| 21 |
17287036 | Altered states: the impact of immediate craving on the valuation of current and future opioids. | 2007 Sep 1 |
3 |